Companies/JP/4931

新日本製薬株式会社 · SHINNIHONSEIYAKU CO., LTD.

Ownership & governance

Executives 3Directors 8Avg age 56Avg tenure 6.3y
Takahiro Goto
Chief Executive Officer
Age 55Since 2021-11-30

Executives3

Takahiro Goto
Chief Executive Officer
Age 55Since 2021-11-30
Mitsuyoshi Fukuhara
Chief Operating Officer
Age 54—
Higuchi Ichimitsu
Corporate Officer/Principal
——

Board of directors8

Takahiro Goto
Director/Board Member
Age 55Since 2005-11-30
Mitsuyoshi Fukuhara
Director/Board Member
Age 54Since 2016-11-30
Sachiyo Yasuda
Director/Board Member
—Since 2023-12-18
Keiichi Zenmyo
Director/Board Member
—Since 2023-12-18
Takashi Tanabe
Director/Board Member
—Since 2023-12-18
Yuji Nakanishi
Director/Board Member
Age 65Since 2023-12-18
Asako Minamitani
Director/Board Member
Age 50Since 2024-12-18
Yukiyo Yasuda
Director/Board Member
——

Shareholders5

NameStakeShares
Eijiro Yamada
18.77 %
4,101,500
Laprise KK
13.64 %
2,980,600
Emi Yamada
13.4 %
2,929,000
Shinnihon Senshin Iryo Kenkyu Zaidan
7.958 %
1,739,200
Takahiro Goto
3.88 %
847,999

Catalog · 2026-07-09

Registry officers10

NameRoleSinceShares
後藤 孝洋代表取締役社長CEO2005-12-01-
中西 裕二取締役(監査等委員)(注)１2002-06-01-
中西 裕二監査役（注）２—-
南谷 朝子取締役(注)１2024-12-01-
善明 啓一取締役(常勤監査等委員)(注)１2013-06-01-
善明 啓一常勤監査役（注）２—-
安田 幸代取締役(注)１2014-04-01-
田邊 俊監査役（注）２—-

Registry · as of 2026-09-30

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 2,190Range 2,190–2,190Analysts 1
  • Hold 1

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers